See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

Nuevas Pequeñas Molécula Drogas Para El Tipo 2  - Ensayos Humanos En Curso

Christoph Westphal, MD, Ph.D - CEO SIRTRIS (GSK)

Nuevas Pequeñas Molécula Drogas Para El Tipo 2  - Ensayos Humanos En Curso

Dr. Sheri Colberg Interviewed by Scott King

Dr. Sheri Colberg

Dr. Sheri Colberg Interviewed by Scott King

Diabetes Health Reference Charts
Medications Archives

Diabetes Medications

Page 3
Stress-Induced Hormone Imbalances Go Far Beyond Insulin in Diabetes

Virtually anything from the stress of a long checkout line to the first signs of menopause can trigger hormone imbalances, which reveal themselves through mood swings, fatigue, migraines, memory problems, and a lackluster sex drive.

Comments 0 comments - Feb 3, 2014 - * * * * *

Skin Cream Could Treat Peripheral Neuropathy

One of the most debilitating risks of diabetes is peripheral neuropathy, which can impact millions of people each year and often leads to amputation.

Comments 0 comments - Feb 2, 2014 - * * * * *

Assessing a New Class of Type 2 Drugs

The name alone is a mouthful. Sodium-glucose cotransporter-2 inhibitors are one of the newest class of drugs meant to treat type 2 diabetes, but you can be forgiven if the name doesn't trip lightly off your tongue. The conspicuously vowel-free abbreviation--SGLT2--isn't much better.

Comments 0 comments - Jan 30, 2014 - * * * * *

Type 1 Drug Wins Orphan Status

DV-100, a drug designed to halt the body's autoimmune attack on pancreatic beta cells that leads to type 1 disease, has won orphan drug status from the U.S. Food and Drug Administration.

Comments 0 comments - Jan 16, 2014 - * * * * *

FDA OKs Dapagliflozin as Type 2 Drug

The Food and Drug Administration has approved the entry of dapagliflozin, a drug for treating type 2 diabetes, into the U.S. market.

Comments 0 comments - Jan 9, 2014 - * * * * *

New Type 2 Drugs Change Treatment Decisions

Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of that population in 1997 to 53 percent in 2012. But that increase has since plateaued due to the introduction of additional drugs that target insulin secretion and glucose regulation.

Comments 0 comments - Jan 4, 2014 - * * * * *

FDA Opens Way for Diabetic Macular Edema Device

The Food and Drug Adminsitration, reversing itself on a decision it made in October, has opened the way for a new treatment for diabetic macular edema to reach the U.S. market.

Comments 0 comments - Jan 1, 2014 - * * * * *

Takeda Ceases Development of Type 2 Drug

Japanese drug maker Takeda, Asia's largest pharmaceutical company, and a major player in the global diabetes medication market, has ceased development of its type 2 drug, TAK-875 (fasiglifam).

Comments 0 comments - Dec 30, 2013 - * * * * *

Danish Drug Improves Blood Sugar Control in Type 2s

Danish pharmaceutical manufacturer Novo Nordisk's drug Ryzodeg, which includes two different insulin products, has been shown to significantly lower rates of hypoglycemia and has led to improved blood sugar levels for those with type 2 diabetes compared to those taking a single insulin, according to the results of a new study.

Comments 0 comments - Dec 27, 2013 - * * * * *

Holiday Classic: A Diabetic Chihuahua Is a Child's Christmas Angel

(Editor's Note:This article originally ran in Diabetes Health on January 27, 2008.)

Comments 0 comments - Dec 25, 2013 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.